Data / Form D filings / PhysioSonics, Inc
PhysioSonics, Inc: Form D filings
PhysioSonics, Inc, a biotechnology company in Bellevue, WA, filed 7 Form D notices with the SEC between 2009 and 2012. The latest, on August 1, 2012, reports $1.5 million sold of a $1.5 million offering to 27 investors.
Find out what PhysioSonics, Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2002 156TH AVENUE NE, STE 150, Bellevue, WA, 98007
- Phone
- (425) 732-2814
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2008
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1437566
The full lists. Form D filings in Washington: 1,095 rows, $54.75, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 1, 2012 | New notice | $1,500,000 | $1,498,830 | $1,170 | 27 | Jul 31, 2012 | sec.gov |
| Jun 28, 2011 | New notice | $72,750 | $72,750 | $0 | 5 | Jun 14, 2011 | sec.gov |
| Feb 4, 2011 | New notice | $4,000,000 | $3,626,055 | $373,945 | 28 | Jan 25, 2011 | sec.gov |
| Jun 2, 2010 | New notice | $1,000,000 | $750,000 | $250,000 | 1 | May 20, 2010 | sec.gov |
| Mar 17, 2010 | New notice | $25,000 | $25,000 | $0 | 1 | Mar 5, 2010 | sec.gov |
| Mar 11, 2010 | New notice | $5,950 | $5,950 | $0 | 1 | Feb 18, 2010 | sec.gov |
| Jun 24, 2009 | New notice | $4,000,000 | $2,000,000 | $2,000,000 | 1 | Jun 18, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Craig C. Drager | Director | |
| Michael J. Schuh | Executive Officer | |
| Lauren C.A. Pflugrath | Director | |
| Brad Harlow | Executive Officer, Director, Promoter | |
| Arthur C. Kirsch | Director | |
| Robert C.A. Frederickson | Director | |
| Kirby C. Cramer | Director |
Other biotechnology companies in Washington that filed recently
- Key Proteo, Inc. $2.3 million · Oct 23, 2026
- Inmedix, Inc. $4 million · Oct 22, 2026
- Q-Immune, Inc. $25,000 · Sep 28, 2026
- Hexamer Therapeutics, Inc $500,000 · Sep 15, 2026
- MalarVx, Inc. $125,000 · Aug 25, 2026
- Strella Biotechnology, Inc. $1.8 million · Aug 14, 2026
Every Form D from the week of Jul 30, 2012 · All recent filings in Washington · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what PhysioSonics, Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.